$216.12
0.83% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
IE00BFY8C754
Symbol
STE

Steris Stock price

$216.12
-8.00 3.57% 1M
-13.05 5.69% 6M
-3.73 1.70% YTD
+14.72 7.31% 1Y
-11.88 5.21% 3Y
+64.62 42.65% 5Y
+153.61 245.74% 10Y
NYSE, Closing price Mon, Nov 25 2024
+1.78 0.83%
ISIN
IE00BFY8C754
Symbol
STE
Sector

Key metrics

Market capitalization $21.33b
Enterprise Value $23.58b
P/E (TTM) P/E ratio 49.36
EV/FCF (TTM) EV/FCF 34.67
EV/Sales (TTM) EV/Sales 4.35
P/S ratio (TTM) P/S ratio 3.93
P/B ratio (TTM) P/B ratio 3.24
Dividend yield 0.94%
Last dividend (FY24) $2.03
Revenue growth (TTM) Revenue growth 3.74%
Revenue (TTM) Revenue $5.42b
EBIT (operating result TTM) EBIT $934.62m
Free Cash Flow (TTM) Free Cash Flow $680.11m
Cash position $172.20m
EPS (TTM) EPS $4.38
P/E forward 31.61
P/S forward 3.89
EV/Sales forward 4.29
Short interest 1.34%
Show more

Is Steris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Steris Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Steris forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a Steris forecast:

Buy
56%
Hold
44%

Financial data from Steris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
5,423 5,423
4% 4%
100%
- Direct Costs 3,084 3,084
4% 4%
57%
2,340 2,340
3% 3%
43%
- Selling and Administrative Expenses 796 796
1% 1%
15%
- Research and Development Expense 106 106
1% 1%
2%
1,438 1,438
4% 4%
27%
- Depreciation and Amortization 503 503
12% 12%
9%
EBIT (Operating Income) EBIT 935 935
15% 15%
17%
Net Profit 435 435
21% 21%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Steris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Steris Stock News

Positive
Seeking Alpha
8 days ago
I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted EPS growth, with strong performance in the Applied Sterilization Technologies segment. Despite high interest rates, I anticipate a gradual recovery in the biotech industry, driving future double-digi...
Positive
Reuters
20 days ago
Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools.
Neutral
GlobeNewsWire
20 days ago
DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 increased 7% to $1.3 billion compared with $1.2 billion in the second quarter of fiscal 2024. Constant currency organi...
More Steris News

Company Profile

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Daniel Carestio
Employees 18,179
Founded 2016
Website www.steris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today